Yearly zoledronic acid in postmenopausal osteoporosis - Reply

被引：0
|
作者：
Black, Dennis [1 ]
Eriksen, Erik
Sellmeyer, Deborah
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94107 USA
[2] Novartis Pharma, CH-4002 Basel, Switzerland
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 357卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：714 / 715
页数：2
相关论文
共 50 条
  • [41] Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis
    H. Taggart
    J. Cheng
    P. Archbold
    Osteoporosis International, 2010, 21 : 1621 - 1622
  • [42] Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis
    Taggart, H.
    Cheng, J.
    Archbold, P.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (09) : 1621 - 1622
  • [43] Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bone, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08): : 3163 - 3170
  • [44] LONG-TERM EFFICACY AND SAFETY OF ZOLEDRONIC ACID IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Gao, Y.
    Zhou, Y.
    Zhang, M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S68 - S68
  • [45] COST-EFFECTIVENESS COMPARISON OF DENOSUMAB AND ZOLEDRONIC ACID IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Ding, Y.
    Hay, J.
    VALUE IN HEALTH, 2014, 17 (03) : A47 - A47
  • [46] Rhabdomyolysis Associated with Intravenous Zoledronic Acid Infusion for the Treatment of Postmenopausal Osteoporosis.
    Schaefer, M. W.
    Gopalakrishnan, G.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [47] COMPARATIVE STUDY OF WEEKLY ALENDRONATE VS. YEARLY ZOLEDRONIC ACID INJECTION IN TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN TERMS OF EFFICACY, COMPLIANCE AND BONE MARKERS ESTIMATION
    Chawla, L.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S196 - S197
  • [48] Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older
    Boonen, Steven
    Black, Dennis M.
    Colon-Emeric, Cathleen S.
    Eastell, Richard
    Magaziner, Jay S.
    Eriksen, Erik Fink
    Mesenbrink, Peter
    Haentjens, Patrick
    Lyles, Kenneth W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (02) : 292 - 299
  • [49] COMPARATIVE STUDY OF WEEKLY ALENDRONATE VS. YEARLY ZOLEDRONIC ACID INJECTION IN TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN TERMS OF EFFICACY, COMPLIANCE AND BONE MARKERS ESTIMATION
    Malhotra, R.
    Chawla, L.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S724 - S724
  • [50] POSTMENOPAUSAL OSTEOPOROSIS - REPLY
    EVANS, RA
    MEDICAL JOURNAL OF AUSTRALIA, 1987, 147 (01) : 48 - 49
12345